You are viewing: Rest Of Europe Long Read Sequencing Market analysis
Part of: Long Read Sequencing Market (Global)

The Rest Of Europe Long Read Sequencing Market was valued at $28.8 Million in 2024 and projected to reach to $123.9 Million by 2029, representing a compound annual growth rate of 33.9%. Rest Of Europe's long read sequencing market is positioned for exceptional growth through 2029, driven by increasing investments in genomic research infrastructure and rising demand for precision medicine applications.

Rest Of Europe Long Read Sequencing Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Rest Of Europe Long Read Sequencing Market Trends and Insights

  • This represents a compound annual growth rate of 33.9%, significantly outpacing global trends and reflecting strong regional adoption of advanced genomic technologies.
  • Rest Of Europe is emerging as a critical hub for precision medicine and genomic research, driven by increasing healthcare investments and growing demand for accurate diagnostic solutions. The market growth in Rest Of Europe is underpinned by rising prevalence of genetic disorders, expanding research infrastructure, and supportive regulatory frameworks across the region.
  • Rest Of Europe's healthcare systems are increasingly integrating long read sequencing into clinical workflows, particularly for cancer genomics and rare disease diagnosis.
  • Between 2024 and 2029, Rest Of Europe is expected to witness accelerated technology adoption, with both public and private sector investments fueling market expansion and innovation in sequencing platforms..

Key Market Statistics

  • CAGR (2024-2029) 33.9% CAGR
  • Market Size, 2024 ~USD 28.8 Million
  • Forecast, 2029 ~USD 123.9 Million
  • Country Rest Of Europe

Rest Of Europe Long Read Sequencing Market Overview

Exceptional Growth Trajectory :

Rest Of Europe's long read sequencing market is expanding at 33.9% CAGR, outpacing the global average of 32.8%, demonstrating accelerated regional adoption and investment in genomic technologies.

Significant Market Expansion :

Market valuation is projected to grow from $28.8 million in 2024 to $123.9 million by 2029, representing a 330% increase over five years and establishing Rest Of Europe as a high-growth genomics region.

Precision Medicine Hub Development :

Rest Of Europe is emerging as a critical center for precision medicine initiatives, with increasing healthcare infrastructure investments and regulatory support driving long read sequencing adoption across clinical and research settings.

Advanced Genomic Technology Adoption :

Strong regional adoption of cutting-edge sequencing technologies reflects growing demand from academic institutions, diagnostic laboratories, and pharmaceutical companies seeking comprehensive genomic insights.

Rest Of Europe Long Read Sequencing Market Dynamics

  • Healthcare systems across the region are prioritizing advanced diagnostic capabilities, creating substantial opportunities for technology providers and service organizations.
  • The market's 33.9% CAGR reflects strong institutional support and growing clinical adoption of long read technologies for complex genetic analysis. Regional factors including favorable regulatory environments, collaborative research networks, and healthcare modernization initiatives are accelerating market expansion.
  • As Rest Of Europe strengthens its position in personalized medicine and genomic research, stakeholders can expect sustained demand for long read sequencing platforms, bioinformatics solutions, and specialized laboratory services throughout the forecast period..

Related Ecosystem

Biotechnology

Top Technologies
  • Reagents
  • Polymerase Chain Reaction (PCR)
  • Stem Cells
  • Assay Kits
  • Flow Cytometers
Top Companies
  • Thermo Fisher Scientific Inc.
  • Merck KGaA
  • Danaher Corporation
  • Agilent Technologies, Inc.
  • Bio-Rad Laboratories, Inc.

    Key Takeaways

    • Rest Of Europe's long read sequencing market is valued at $28.8 million in 2024 and will grow to $123.9 million by 2029, representing a 33.9% CAGR.
    • Rest Of Europe demonstrates stronger growth momentum than the global market, driven by increased genomic research funding and precision medicine initiatives.
    • Rest Of Europe's healthcare systems are rapidly adopting long read sequencing for clinical diagnostics, particularly in oncology and rare disease applications.
    • Rest Of Europe's market expansion is supported by favorable regulatory environments and growing collaboration between academic institutions and commercial sequencing providers.

    Long Read Sequencing Market Report Scope

    Report Metric Details
    Base Year 2024
    Fastest Growing Segment DATA ANALYSIS (Workflow)
    Forecast Period 2024-2029
    Growth Rate CAGR of 32.8% from 2024 to 2029
    Largest Segment RESEARCH USAGE (Usage)
    Market Size Base Year (Billions) ~USD 0.76 (2024)
    Revenue Forecast (Billions) ~USD 3.13 (2029)
    Segments Covered Offering, Technology, Workflow, Application, Usage, End User

    Rest Of Europe Long Read Sequencing Market Report Segmentation

    6 segment dimensions are covered across the global market.

    By Offering

    • Consumables
    • Instruments
    • Services

    By Technology

    • Nanopore Sequencing
    • Single-Molecule Real-Time Sequencing
    • Synthetic Long-Read Sequencing

    By Workflow

    • Data Analysis
    • Sample Preparation
    • Sequencing

    By Application

    • Epigenetics
    • Metagenomics
    • Other Applications
    • Targeted Sequencing
    • Whole-Exome Sequencing
    • Whole-Genome Sequencing

    By Usage

    • Clinical Usage
    • Research Usage

    By End User

    • Academic & Research Institute
    • Academic & Research Institutes
    • Hospitals, Clinics & Diagnostic
    • Hospitals, Clinics, And Diagnostic Labs
    • Other End User
    • Other End Users
    • Pharmaceutical & Biotechnologies Companies
    • Pharmaceutical & Biotechnology Companies
    • Pharmaceutical & Biotechnology Companies Labs

    Target Audience

    • Genomics Technology Providers : Sequencing platform manufacturers and bioinformatics companies need Rest Of Europe market data to identify growth opportunities, assess regional demand, and develop localized product strategies.
    • Healthcare & Diagnostic Organizations : Clinical laboratories and diagnostic centers require market intelligence to benchmark performance, understand competitive positioning, and plan investments in long read sequencing capabilities.
    • Pharmaceutical & Biotech Companies : Drug developers and biotech firms need regional market insights to evaluate Rest Of Europe as a research hub, identify collaboration opportunities, and plan precision medicine initiatives.
    • Healthcare Investors & Consultants : Investment firms and management consultants require detailed market analysis to evaluate Rest Of Europe's genomics sector attractiveness, growth potential, and investment opportunities.
    • Academic & Research Institutions : Universities and research centers need market data to understand funding landscapes, identify technology partnerships, and position their genomics research within the regional ecosystem.

    Reasons to Buy this Report

    • Regional Market Sizing & Forecasting : Obtain precise market valuations and growth projections specific to Rest Of Europe, enabling accurate budget allocation and strategic planning for regional expansion initiatives.
    • Competitive Landscape Intelligence : Understand Rest Of Europe's unique competitive dynamics, key players, and market positioning to identify partnership opportunities and differentiation strategies in this high-growth region.
    • Growth Driver Analysis : Identify region-specific factors driving the 33.9% CAGR, including regulatory developments, healthcare infrastructure investments, and clinical adoption trends unique to Rest Of Europe.
    • Investment & Expansion Strategy : Leverage detailed market insights to make informed decisions about market entry, facility establishment, or product localization strategies tailored to Rest Of Europe's specific needs.
    • Customer Segmentation & Targeting : Access Rest Of Europe-specific customer profiles, institutional buyers, and end-user segments to optimize sales strategies and marketing campaigns for maximum regional impact.

    Frequently asked questions

    What is the current market size of long read sequencing in Rest Of Europe?

    Rest Of Europe's long read sequencing market was valued at $28.8 million in 2024 and is projected to reach $123.9 million by 2029.

    What is the expected growth rate for long read sequencing in Rest Of Europe?

    Rest Of Europe's long read sequencing market is expected to grow at a compound annual growth rate (CAGR) of 33.9% from 2024 to 2029.

    Which applications are driving long read sequencing adoption in Rest Of Europe?

    Rest Of Europe is seeing increased adoption of long read sequencing in cancer genomics, rare disease diagnosis, and structural variant detection within clinical and research settings.

    What factors are contributing to market growth in Rest Of Europe?

    Rest Of Europe's market growth is driven by rising genetic disorder prevalence, expanding research infrastructure, supportive regulatory frameworks, and increased healthcare investments in precision medicine.

    How does Rest Of Europe's growth compare to the global market?

    Rest Of Europe's 33.9% CAGR exceeds the global market CAGR of 32.8%, indicating stronger regional adoption and investment in long read sequencing technologies.

    RESEARCH METHODOLOGY

    This study on the long-read sequencing market employed secondary sources, directories, and databases to gather pertinent information. To gather and validate important qualitative and quantitative data and evaluate market growth prospects, in-depth interviews were conducted with many primary respondents including key industry participants, subject-matter experts (SMEs), C-level executives from key market players, and industry consultants. After estimating the long-read sequencing market using several research strategies, the size of the final market was obtained by triangulating data from primary research.

    Secondary Research

    The secondary sources referred to for this research study include publications from government sources. These include Nucleic Acids Research, Genome Biology, Nature Reviews Genetics, Nature Methods, Genome Research, International Journal of Genomics, National Human Genome Research Institute (NHGRI), International Chromosome and Genome Society (ICGS), Genome Canada, European Society of Human Genetics (ESHG), Genomics England, Genome British Columbia, Beijing Institute of Genomics, Centre for Cellular & Molecular Biology (CCMB), São Paulo Research Foundation (FAPESP), National Cancer Institute (NCI), European Medicines Agency (EMA), Biotechnology and Biological Sciences Research Council (BBSRC), Organisation for Economic Co-operation and Development (OECD), Population Health Research Institute (PHRI),  PubMed, World Bank, and the World Health Organization (WHO), among others. Secondary sources also included corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations. Secondary data was collected and analyzed to arrive at the overall size of the global long-read sequencing market, which was validated through primary research.

    Primary Research

    Extensive primary research was conducted after acquiring basic knowledge about the global long-read sequencing market scenario through secondary research. Several primary interviews were conducted with market experts from the supply side, such as C-level and D-level executives, operational managers, marketing & sales managers of key manufacturers, distributors, and channel partners of companies providing long-read sequencing; experts from the demand side, such as personnel from academic & research institutes, hospitals, clinics and diagnostic labs, pharmaceutical & biopharmaceutical industries. These interviews were conducted across six major regions, including North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

    The following is a breakdown of the primary respondents:

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the long-read sequencing market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Bottom-up Approach

    • The key players in the industry and market have been identified through extensive secondary research.
    • The revenues generated from the long-read sequencing market business of leading players have been determined through primary and secondary research.
    • All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.

    Long Read Sequencing Market Size, and Share

    To know about the assumptions considered for the study, Request for Free Sample Report

    Top-down Approach

    After arriving at the overall market size from the market size estimation process, the total market was split into several segments and subsegments.

    Long Read Sequencing Market Size, and Share

    Data Triangulation

    To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

    Market Definition

    Long-read sequencing is a type of nucleic acid sequencing that produces genomic data by generating individual reads from single molecules, generally ranging in size from 700 to over 20,000 bases. These fragments are typically derived from "native" molecules, which are directly extracted from biological samples for analysis. The long-read sequencing market encompasses the consumables, instruments, services, and technology associated with long-read sequencing. The long-read sequencing market is defined as solutions including instruments/systems, consumables (kits, reagents, flow cells), and services for long-read sample preparation, sequencing, and data analysis. Long-read software solutions are often provided alongside the instrument/system/platform, hence the software solutions are considered within the instrument segment scope. Other standalone software solutions are provided as data analysis services and are considered within the services segment scope.

    Stakeholders

    • Academic & Research Institutes
    • Software & Bioinformatics Companies
    • Healthcare & Clinical Laboratories
    • Long-Read Sequencing Technology Vendors
    • Contract Research Organizations (CROs)
    • Market Research and Consulting Firms
    • Pharmaceutical & Biotechnology Companies
    • Regulatory Agencies
    • Venture Capitalists
    • Government Organizations
    • Industry Associations and Professional Societies

    Report Objectives

    • To define, describe, and forecast the long-read sequencing market based on offerings, technology, workflow, application, usage, end user, and region
    • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall long-read sequencing market
    • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
    • To forecast the size of the market segments with respect to six main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East, and Africa
    • To profile the key players in the global long-read sequencing market and comprehensively analyze their instruments, consumables, and services portfolios, market positions, and core competencies
    • To track and analyze competitive developments such as product & service launches, expansions, agreements, and collaborations in the long-read sequencing market
    • To benchmark players within the long-read sequencing market using the ‘Company Evaluation Matrix' framework, which analyzes market players based on various parameters within the broad categories of business and service strategy

    Available Customizations

    With the given market data, MarketsandMarkets offers customizations as per the company’s specific needs. The following customization options are available for the report:

    Geographical Analysis

    • Further breakdown of the Rest of Europe Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Asia Pacific Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Latin America Long-Read Sequencing Market, by country
    • Further breakdown of the Rest of Middle East Long-Read Sequencing Market, by country

    Company Information

    • Detailed analysis and profiling of additional market players (up to five)

    Segment Analysis

    • Further breakdown of the other application and other end users area into subsegments
    • Cross-segment analysis

    Get the Full Long Read Sequencing Market Report

    Full forecast, segment splits, and company analysis for all Long Read Sequencing Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status